Clinicopathological Significance of ATM-Chk2 Expression in Sporadic Breast Cancers: a Comprehensive Analysis in Large Cohorts-Reference-Cited by-同舟云学术

Clinicopathological Significance of ATM-Chk2 Expression in Sporadic Breast Cancers: a Comprehensive Analysis in Large Cohorts

Published:2014-11 Issue:11 Volume:16 Page:982-991
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Abdel-Fatah Tarek M.A.,Arora Arvind,Alsubhi Nouf,Agarwal Devika,Moseley Paul M.,Perry Christina,Doherty Rachel,Chan Stephen Y.T.,Green Andrew R.,Rakha Emad,Ball Graham,Ellis Ian O.,Madhusudan Srinivasan

Publisher

Elsevier BV

Subject

Cancer Research

Reference45 articles.

1. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more Nature reviews;Shiloh;Mol Cell Biol,2013

2. DNA damage sensing by the ATM and ATR kinases;Marechal;Cold Spring Harb Perspect Biol,2013

3. Pathogenesis of ataxia–telangiectasia: the next generation of ATM functions;Ambrose;Blood,2013

4. The ATM protein kinase and cellular redox signaling: beyond the DNA damage response;Ditch;Trends Biochem Sci,2012

5. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer;Smith;Adv Cancer Res,2010

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical findings and clinicopathological features of breast cancers with pathogenic germline mutations in Non-BRCA genes;Human Pathology;2024-04

2. Relationship between the Expression of CHK2 and p53 in Tumor Tissue and the Course of Papillary Thyroid Cancer in Patients with CHEK2 Germline Mutations;Cancers;2024-02-17

3. Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness;Science Advances;2023-06-30

4. Investigation of mRNA Expression Levels of Tip60 and Related DNA Repair Genes in Molecular Subtypes of Breast Cancer;Clinical Breast Cancer;2023-02

5. DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities;Experimental & Molecular Medicine;2022-10-07